ClinicalTrials.govpublic full text
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
chronic kidney disease, chronic kidney disease (ckd), cardiovascular events (cv), phase iii outcome trial, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 865428
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.